Serum osteoprotegerin is associated with arterial stiffness assessed according to the cardio-ankle vascular index in hypertensive patients

Journal of Atherosclerosis and Thrombosis

Volumn 22, Issue 3, 2015, Pages 304-312

  Lee, Chung Jen ^a   Wang, Ji Hung ^b,c   Chen, Mei Ling ^b   Yang, Chiu Fen ^b   Chen, Yu Chih ^b   Hsu, Bang Gee ^b,c  

^a TZU CHI COLLEGE OF TECHNOLOGY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Arterial stiffness; Cardio ankle vascular index; Hypertension; Osteoprotegerin

Indexed keywords

C REACTIVE PROTEIN; CREATININE; OSTEOPROTEGERIN;

ADULT; AGING; ANTHROPOMETRY; ARTERIAL STIFFNESS; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOANKLE VASCULAR INDEX; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PULSE PRESSURE; PULSE WAVE; QUANTITATIVE ANALYSIS; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; AGED; ANKLE; BLOOD; CASE CONTROL STUDY; VASCULARIZATION;

AGED; ANKLE; CASE-CONTROL STUDIES; HUMANS; HYPERTENSION; MIDDLE AGED; OSTEOPROTEGERIN; VASCULAR STIFFNESS;

EID: 84925351570     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.25882     Document Type: Article

References (36)

1. Venuraju SM, Yerramasu A, Corder R, Lahiri A, Venuraju SM: Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity. J Am CollCardiol, 2010; 55: 2049-2061
2. Van Campenhout A, Golledge J: Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis, 2009; 204: 321-329
3. Vlachopoulos C, Aznaouridis K, Stefanadis C: Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol, 2010; 55: 1318-1327
4. Shirai K, Hiruta N, Song M, Kurosu T, Suzuki J, Tomaru T, Miyashita Y, Saiki A, Takahashi M, Suzuki K, Takata M: Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb, 2011; 18: 924-938
5. Sun CK: Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness. Integr Blood Press Control, 2013; 6: 27-38
6. Kim HR, Kim SH, Han MJ, Yoon YS, Oh DJ: The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients. Nephron Clin Pract, 2013; 123: 165-172
7. Damasceno A, Azevedo A, Silva-Matos C, Prista A, Diogo D, Lunet N: Hypertension prevalence, awareness, treatment, and control in mozambique: Urban/rural gap during epidemiological transition. Hypertension, 2009; 54: 77-83
8. Trudeau L: Central blood pressure as an index of antihypertensive control: determinants and potential value. Can J Cardiol, 2014; 30 (5 Suppl): S23-S28
9. Wang JH, Lee CJ, Chen ML, Yang CF, Chen YC, Hsu BG: Association of serum osteoprotegerin levels with carotidfemoral pulse wave velocity in hypertensive patients. J Clin Hypertens (Greenwich), 2014; 16: 301-308
10. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitusand its complications. I. Diagnosis and classification of diabetes mellitus provisionalreport of a WHO consultation. Diabet Med, 1998; 15: 539-553
11. Chen YC, Lee MC, Lee CJ, Ho GJ, Yin WY, Chang YJ, Hsu BG: N-terminal pro-B-type natriuretic peptide associated witharterial stiffness by cardio-ankle vascular index in renal transplant recipients. J Atheroscler Thromb, 2013; 20: 647-654
12. Antonini-Canterin F, Carerj S, Di Bello V, Di Salvo G, La Carrubba S, Vriz O, Pavan D, Balbarini A, Nicolosi GL; Research Group of the Italian Society of Cardiovascular Echography (SIEC): Arterial stiffness and ventricular stiffness: a couple of diseases or a coupling disease ? A reviewfrom the cardiologist's point of view. Eur J Echocardiogr, 2009; 10: 36-43
13. Ohira T, Iso H: Cardiovascular disease epidemiology in Asia: an overview. Circ J, 2013; 77: 1646-1652
14. Shirai K, Utino J, Saiki A, Endo K, Ohira M, Nagayama D, Tatsuno I, Shimizu K, Takahashi M, Takahara A: Evaluation of blood pressure control using a new arterial stiffness parameter, cardio-ankle vascular index (CAVI). Curr Hypertens Rev, 2013; 9: 66-75
15. Ibata J, Sasaki H, Kakimoto T, Matsuno S, Nakatani M, Kobayashi M, Tatsumi K, Nakano Y, Wakasaki H, Furuta H, Nishi M, Nanjo K: Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure. Diabetes Res Clin Pract, 2008; 80: 265-270
16. Masugata H, Senda S, Inukai M, Murao K, Himoto T, Hosomi N, Murakami K, Noma T, Kohno M, Okada H, Goda F: Association of cardio-ankle vascular index with brain natriuretic peptide levels in hypertension. J Atheroscler Thromb, 2012; 19: 255-262
17. Doonan RJ, Hausvater A, Scallan C, Mikhailidis DP, Pilote L, Daskalopoulou SS: The effect of smoking on arterial stiffness. Hypertens Res, 2010; 33: 398-410
18. Kubozono T, Miyata M, Ueyama K, Hamasaki S, Kusano K, Kubozono O, Tei C: Acute and chronic effects of smoking on arterial stiffness. Circ J, 2011; 75: 698-702
19. Noike H, Nakamura K, Sugiyama Y, Iizuka T, Shimizu K, Takahashi M, Hirano K, Suzuki M, Mikamo H, Nakagami T, Shirai K: Changes in cardio-ankle vascular index in smoking cessation. J Atheroscler Thromb, 2010; 17: 517-525
20. Lakatta EG: Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation, 2003; 107: 490-497
21. Choi SY, Oh BH, Bae Park J, Choi DJ, Rhee MY, Park S: Age-associated increase in arterial stiffness measured according to the cardio-ankle vascular index without blood pressure changes in healthy adults. J Atheroscler Thromb, 2013; 20: 911-923
22. Stehouwer CD, Henry RM, Ferreira I: Arterialstiffness in diabetes and the metabolicsyndrome: a pathway to cardiovascular disease. Diabetologia, 2008; 51: 527-539
23. Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH: Aortic stiffness: current understanding and future directions. J Am Coll Cardiol, 2011; 57: 1511-1522
24. Kubozono T, Miyata M, Ueyama K, Nagaki A, Hamasaki S, Kusano K, Kubozono O, Tei C: Association between arterial stiffness and estimated glomerular filtration rate in the Japanese general population. J Atheroscler Thromb, 2009; 16: 840-845
25. Nakamura K, Iizuka T, Takahashi M, Shimizu K, Mikamo H, Nakagami T, Suzuki M, Hirano K, Sugiyama Y, Tomaru T, Miyashita Y, Shirai K, Noike H: Association between cardio-ankle vascular index and serum cystatin C levels in patients with cardiovascular risk factor. J Atheroscler Thromb, 2009; 16: 371-379
26. Yamashita H, Nishino T, Obata Y, Nakazato M, Inoue K, Furusu A, Takamura N, Maeda T, Ozono Y, Kohno S: Association between cystatin C and arteriosclerosis in the absence of chronic kidney disease. J Atheroscler Thromb, 2013; 20: 548-556
27. Schillaci G, Pirro M, Mannarino MR, Pucci G, Savarese G, Franklin SS, Mannarino E: Relation between renalfunction within the normal range and central and peripheral arterial stiffness in hypertension. Hypertension, 2006; 48: 616-621
28. Karwowski W, Naumnik B, Szczepanski M, Mysliwiec M: The mechanism of vascular calcification - a systematic review. Med Sci Monit, 2012; 18: RA1-11
29. Persy V, D'Haese P: Vascular calcification and bone disease: the calcificationparadox. Trends Mol Med, 2009; 15: 405-416
30. Baud'huin M, Duplomb L, Teletchea S, Lamoureux F, Ruiz-Velasco C, Maillasson M, Redini F, Heymann MF, Heymann D: Osteoprotegerin: multiple partners for multiple functions. Cytokine Growth Factor Rev, 2013; 24: 401-409
31. Uzui H, Morishita T, Nakano A, Amaya N, Fukuoka Y, Ishida K, Arakawa K, Lee JD, Tada H: Effects of combination therapy with olmesartan and azelnidipine on serum osteoprotegerin in patients with hypertension. J Cardiovasc Pharmacol Ther, 2014; 19: 304-309
32. Miyashita Y, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohira M, Oyama T, Shirai K: Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio- AnkleVascularIndex (CAVI) in type 2 diabetic patients with hypertension. J Atheroscler Thromb, 2009; 16: 621- 626
33. Sasaki H, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohhira M, Oyama T, Miyashita Y, Shirai K: Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy. J Atheroscler Thromb, 2009; 16: 568-575
34. Kinouchi K, Ichihara A, Sakoda M, Kurauchi-Mito A, Murohashi-Bokuda K, Itoh H: Effects of telmisartan on arterial stiffness assessed by the cardio-anklevascularindex in hypertensive patients. Kidney Blood Press Res, 2010; 33: 304-312
35. Miyashita Y, Endo K, Saiki A, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohira M, Oyama T, Shirai K: Effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardio-ankle vascular index in type 2 diabetic patients. J Atheroscler Thromb, 2009; 16: 539-545
36. Shirai K, Song M, Suzuki J, Kurosu T, Oyama T, Nagayama D, Miyashita Y, Yamamura S, Takahashi M: Contradictory effects of β1- and α1-aderenergic receptor blockers on cardio-ankle vascular stiffness index (CAVI)- CAVI independent of blood pressure. J Atheroscler Thromb, 2011; 18: 49-55